What is Xylo Technologies Price-to-Free-Cash-Flow?
As of today (2024-05-05), Xylo Technologies's share price is $1.52.
Xylo Technologies's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $-4.75. Hence, Xylo Technologies's Price-to-Free-Cash-Flow Ratio for today is N/A.
The historical rank and industry rank for Xylo Technologies's Price-to-Free-Cash-Flow or its related term are showing as below:
XYLO's Price-to-Free-Cash-Flow is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 33.33 * Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
During the past 3 years, the average Free Cash Flow per Share Growth Rate was 31.20% per year.
During the past 5 years, the average Free Cash Flow per Share Growth Rate was 31.70% per year.
During the past 10 years, the average Free Cash Flow per Share Growth Rate was 50.40% per year.
During the past 12 years, Xylo Technologies's highest 3-Year average Free Cash Flow per Share Growth Rate was 76.80% per year. The lowest was 19.90% per year. And the median was 39.30% per year.
Xylo Technologies Price-to-Free-Cash-Flow Historical Data
The historical data trend for Xylo Technologies's Price-to-Free-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Xylo Technologies's Price-to-Free-Cash-Flow
For the Medical Devices subindustry, Xylo Technologies's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Xylo Technologies's Price-to-Free-Cash-Flow Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Xylo Technologies's Price-to-Free-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Xylo Technologies's Price-to-Free-Cash-Flow falls into.
Xylo Technologies's Share Price of today is $1.52.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Xylo Technologies's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $-4.75.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.
In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.
Be Aware
In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.
Xylo Technologies Price-to-Free-Cash-Flow Related Terms
Thank you for viewing the detailed overview of Xylo Technologies's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.
Xylo Technologies (Xylo Technologies) Business Description
Medigus Ltd is an Israel-based medical device company. It is engaged in the development, manufacturing, and marketing of surgical endostaplers and direct vision systems for minimally invasive medical procedures. The key product of the company is the MUSE (Medigus Ultrasonic Surgical Endostapler) system is a single-use device for the incisionless treatment of GERD (gastroesophageal reflux disease), which is based on proprietary platform technology and know-how. The company also develops a range of micro video cameras under the micro ScoutCam portfolio of products. It operates in five segments: Medical, E-Commerce, Online, Electric Vehicles, and Corporate. The company's geographical segments include the United States, United Kingdom, Germany, Israel, China, and Others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XYLO has been successfully added to your 